Omineca Jump: All Uphill Now?
Source: Chris Temple  (1/6/25)
Chris Temple of The National Investor shares his thoughts on Omineca Mining and Metals Ltd. (OMM:TSX.V; OMMSF:OTCMKTS) as we head into the new year. More >

Is Ecuador's Environment Improving at All?
Source: Chris Temple  (1/6/25)
Chris Temple of The National Investor shares his thoughts on what is going on in Ecuador and takes a look at two companies in the country: BacTech Environmental Corp. (BAC:CSE; BCCEF:OTC; OBT1:FSE) and Salazar Resources Ltd (SRL:TSX.V; SRLZF:OTCQX). More >

Coming Soon: Wine From Your Favorite Social Media Creators
Source: Streetwise Reports  (1/3/25)
A recently announced merger agreement between Amaze Software Inc. and wine company Fresh Vine Wine Inc. will allow social media creators to expand their product offerings to include high-quality wine and spirits. More >

Strategic Investments Accelerate Gold Exploration in West Africa
Source: Streetwise Reports  (1/3/25)
Sanu Gold Corp. (SANU:CSE; SNGCF:OTCQB; L73:FRA) secures US$7.3 million in strategic funding to drive exploration in Guinea. Find out why the CEO says this news could accelerate the exploration of the company's high-potential gold projects in Guinea. More >

Copper Explorer Secures US$2.73 Million to Advance Key Projects
Source: Streetwise Reports  (1/3/25)
Giant Mining Corp. (CSE: BFG; OTC:BFGFF; FWB:YW5) has raised US$2.73 million through a private placement and LIFE offering. Find out how this funding advances their copper exploration projects.

More >

Pharma Innovator Unlocks Multi-Disease Treatment Potential
Source: Jason Kolbert  (1/3/25)
Quince Therapeutics Inc. is "positioned for a transformative year" in 2025 with a solid cash position of US$47.8 million as of the third quarter of 2024. Find out why one analyst gives the stock a Buy rating. More >

Drug Innovator Launches Pivotal Cancer Trial Breakthrough
Source: Sean Lee  (1/3/25)
Corvus Pharmaceuticals, Inc. (CRVS:NASDAQ) has the potential to generate hundreds of millions of dollars over the next decade with its drug candidates, an H.C. Wainwright & Co. analyst wrote in a January 2 research note. More >

Stocks Are Bouncing
  (1/3/25)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market and one gold stock he thinks is a Buy. More >

High-Grade Gold Discoveries in Nevada Reveal Significant Potential For 2025
Source: Streetwise Reports  (1/3/25)
Nevada King Gold Corp. (NKGFF:OTCMKTS; NKG:TSX) continues to advance its Atlanta Gold Project with high-grade discoveries and resource expansion potential. Learn whats driving their success and whats next for this Nevada asset.

More >

Should You Buy on These Silver Stock Dips?
Source: Shad Marquitz  (1/2/25)
Shad Marquitz of Excelsior Prosperity explains why he plans to buy silver stock juniors on dips. More >

Liberia's Dugbe Gold Project: A Strategic Asset Driving Growth and Sustainability
Source: Streetwise Reports  (1/2/25)
Pasofino Gold Ltd. (VEIN:TSX.V) is a Canadian-based mineral exploration company listed on the TSX Venture Exchange and Frankfurt Stock Exchange. Read more to see why one technical analyst thinks the stock is an Immediate Strong Buy. More >

Why 4 Experts Like Argentinean-Focused Silver and Gold Explorer
Source: Streetwise Reports  (1/2/25)
Their numerous reasons include the project's location, size, projected economics, resource growth potential and likelihood to be taken out. Read on for the specifics. More >

Miami Biopharma Sells Part of Business and Begins New Clinical Trial
Source: Dr. Yi Chen  (1/2/25)
Miami biopharmaceutical company Veru Inc. (VERU:NASDAQ) recently sold its FC2 Female Condom business for US$18 million, and has begun enrolling patients for its The Phase 2b QUALITY trial of enobosarm in combination with Wegovy (semaglutide) for sarcopenic obesity. Read on to see why one analyst gives this company a Buy rating. More >

Massive High-Grade Discovery in Newfoundland Exceeds Expectations
Source: Streetwise Reports  (1/2/25)
Canterra Minerals Corp. (CTM:TSX.V; CTMCF:OTC) uncovers high-grade silver potential at its Nevada project. Could this discovery redefine the region's mining landscape in 2025? More >

Gold Developer Unlocks Major Funding for Historic Canadian Mine
Source: Streetwise Reports  (1/2/25)
West Red Lake Gold Mines Inc. (WRLG:TSX.V; WRLGF:OTCQB) announces the completion of a US$35 million credit facility with Nebari Natural Resources Credit Fund II LP. Find out why one analyst writes that the company's exploration plans have "good potential for resource expansion." More >

Opening Volatility
Source: Michael Ballanger  (1/2/25)
Michael Ballanger of GGM Advisory Inc. takes a look at VIS:US this morning. More >

Dakota Gold Co. Announces Positive Drill Results
Source: Peter Bell  (1/1/25)
Dakota Gold Corp. (DC:NYSE American) recently announced positive drill results from Chism Gulch at its 100%-owned Richmond Hill Gold Project, according to a Canaccord Genuity Corp. research note. More >

Gold Explorer Ready To Break Out of a Large Base
Source: Clive Maund  (12/31/24)
Technical Analyst Clive Maund explains why he thinks Pasofino Gold Ltd. (VEIN:TSX.V) is an Immediate Strong Buy. More >

Advanced Counter-Drone Solutions Drive Growth in Emerging Security Industry
Source: Streetwise Reports  (12/31/24)
DroneShield Ltd. (DRO:ASX; DRSHF:OTC) has advanced its portfolio of detection and neutralization solutions to become a prominent developer of counter-drone technologies in the counter-unmanned aerial systems industry. Read more to find out how this innovative approach is shaping the future of counter-drone technology and driving growth in the C-UAS sector. More >

Strategic Executive Hires Propel Lithium Company Forward
Source: Streetwise Reports  (12/31/24)
Atlas Lithium Corp. (ATLX:NASDAQ), situated in Brazil's Lithium Valley, has made two strategic executive hires to strengthen its production capabilities and global market presence. Read more about these new hires and their roles in advancing production and expanding global reach. More >

Analyst Initiates Coverage of Co. With 'Once-in-a-Generation' Drug
Source: Ed Arce  (12/31/24)
NewAmsterdam Pharma Company N.V.'s (NAMS:NASDAQ) drug obicetrapib is a "once-in-a-generation" drug for cardiovascular disease, an analyst wrote in a research note while initiating coverage on the company. See what rating the stock got and its price per share target. More >

Analyst Sees Major Growth for Biopharma With Weight-Loss Drug
Source: Ed Arce  (12/31/24)
Recent successes of weight-loss drugs like Ozempic and Wegovy have led H.C. Wainwright & Co. Analyst Ed Arce to be "intrigued" by MetaVia Inc.'s (MTVA:NASDAQ) new drug candidate. More >

One Contrarian Buy in the Lithium Space
Source: Michael Ballanger  (12/31/24)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market and one lithium stock he considers a Buy despite market sentiment. More >

New Metallurgical Findings Would Boost Project NAV
Source: Varun Arora  (12/30/24)
Improved metals recoveries make the economics of this three-deposit, polymetallic project in Spain compelling, noted a Clarus Securities report. More >

Stocks Look To Add to the Friday Losses
Source: Michael Ballanger  (12/30/24)
Michael Ballanger of GGM Advisory Inc. shares his thoughts on the current state of the market as we head into the new year. More >